FHIR IG Statistics: ValueSet/2.16.840.1.113762.1.4.1078.1043
Package | us.nlm.vsac |
Resource Type | ValueSet |
Id | 2.16.840.1.113762.1.4.1078.1043 |
FHIR Version | R4 |
Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1078.1043/expansion |
URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1043 |
Version | 20250501 |
Status | active |
Date | 2025-05-01T01:08:08-04:00 |
Name | AnemiaForErythropoesisSimulatingAgentsI10 |
Title | Anemia for Erythropoesis Simulating Agents I10 |
Realm | us |
Authority | hl7 |
Purpose | (Clinical Focus: Codes indicating a diagnosis of anemia for which erythropoesis stimulating agents would be appropriate.),(Data Element Scope: ),(Inclusion Criteria: ICD-10-CM codes for anemia, including aplastic and other bone marrow failure syndromes (D60-D64)),(Exclusion Criteria: * Nutritional anemias (e.g., iron, folate, B12), * hemolytic anemias, * anemia due to enzyme disorders *post-hemorrhagic anemia) |
Resources that use this resource
Resources that this resource uses
CodeSystem |
icd-10-cm | International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM) |
Narrative
No narrative content found in resource
Source
{
"resourceType": "ValueSet",
"id": "2.16.840.1.113762.1.4.1078.1043",
"meta": {
"versionId": "6",
"lastUpdated": "2025-05-01T01:08:08.000-04:00",
"profile": [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
]
},
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail": {
"name": "Optum Author"
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate": "2025-05-01"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate": "2025-05-01"
}
],
"url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1043",
"identifier": [
{
"system": "urn:ietf:rfc:3986",
"value": "urn:oid:2.16.840.1.113762.1.4.1078.1043"
}
],
"version": "20250501",
"name": "AnemiaForErythropoesisSimulatingAgentsI10",
"title": "Anemia for Erythropoesis Simulating Agents I10",
"status": "active",
"date": "2025-05-01T01:08:08-04:00",
"publisher": "Optum Steward",
"jurisdiction": [
{
"coding": [
{
"system": "urn:iso:std:iso:3166",
"code": "US"
}
]
}
],
"purpose": "(Clinical Focus: Codes indicating a diagnosis of anemia for which erythropoesis stimulating agents would be appropriate.),(Data Element Scope: ),(Inclusion Criteria: ICD-10-CM codes for anemia, including aplastic and other bone marrow failure syndromes (D60-D64)),(Exclusion Criteria: * Nutritional anemias (e.g., iron, folate, B12), * hemolytic anemias, * anemia due to enzyme disorders *post-hemorrhagic anemia)",
"compose": {
"include": [
{
"system": "http://hl7.org/fhir/sid/icd-10-cm",
"version": "2025",
"filter": [
{
"property": "concept",
"op": "descendent-of",
"value": "D60"
}
]
},
{
"system": "http://hl7.org/fhir/sid/icd-10-cm",
"version": "2025",
"filter": [
{
"property": "concept",
"op": "is-a",
"value": "D61"
}
]
},
{
"system": "http://hl7.org/fhir/sid/icd-10-cm",
"version": "2025",
"filter": [
{
"property": "concept",
"op": "is-a",
"value": "D63"
}
]
},
{
"system": "http://hl7.org/fhir/sid/icd-10-cm",
"version": "2025",
"filter": [
{
"property": "concept",
"op": "is-a",
"value": "D64"
}
]
}
]
},
"expansion": {
"identifier": "urn:uuid:d19d7636-027c-4cf4-8689-2ec908992444",
"timestamp": "2025-05-23T17:45:01-04:00",
"total": 35,
"contains": [
{
"system": "http://hl7.org/fhir/sid/icd-10-cm",
"version": "2025",
"code": "D60.0",
"display": "Chronic acquired pure red cell aplasia"
},
{
"system": "http://hl7.org/fhir/sid/icd-10-cm",
"version": "2025",
"code": "D60.1",
"display": "Transient acquired pure red cell aplasia"
},
{
"system": "http://hl7.org/fhir/sid/icd-10-cm",
"version": "2025",
"code": "D60.8",
"display": "Other acquired pure red cell aplasias"
},
{
"system": "http://hl7.org/fhir/sid/icd-10-cm",
"version": "2025",
"code": "D60.9",
"display": "Acquired pure red cell aplasia, unspecified"
},
{
"system": "http://hl7.org/fhir/sid/icd-10-cm",
"version": "2025",
"code": "D61",
"display": "Other aplastic anemias and other bone marrow failure syndromes"
},
{
"system": "http://hl7.org/fhir/sid/icd-10-cm",
"version": "2025",
"code": "D61.0",
"display": "Constitutional aplastic anemia"
},
{
"system": "http://hl7.org/fhir/sid/icd-10-cm",
"version": "2025",
"code": "D61.01",
"display": "Constitutional (pure) red blood cell aplasia"
},
{
"system": "http://hl7.org/fhir/sid/icd-10-cm",
"version": "2025",
"code": "D61.02",
"display": "Shwachman-Diamond syndrome"
},
{
"system": "http://hl7.org/fhir/sid/icd-10-cm",
"version": "2025",
"code": "D61.03",
"display": "Fanconi anemia"
},
{
"system": "http://hl7.org/fhir/sid/icd-10-cm",
"version": "2025",
"code": "D61.09",
"display": "Other constitutional aplastic anemia"
},
{
"system": "http://hl7.org/fhir/sid/icd-10-cm",
"version": "2025",
"code": "D61.1",
"display": "Drug-induced aplastic anemia"
},
{
"system": "http://hl7.org/fhir/sid/icd-10-cm",
"version": "2025",
"code": "D61.2",
"display": "Aplastic anemia due to other external agents"
},
{
"system": "http://hl7.org/fhir/sid/icd-10-cm",
"version": "2025",
"code": "D61.3",
"display": "Idiopathic aplastic anemia"
},
{
"system": "http://hl7.org/fhir/sid/icd-10-cm",
"version": "2025",
"code": "D61.8",
"display": "Other specified aplastic anemias and other bone marrow failure syndromes"
},
{
"system": "http://hl7.org/fhir/sid/icd-10-cm",
"version": "2025",
"code": "D61.81",
"display": "Pancytopenia"
},
{
"system": "http://hl7.org/fhir/sid/icd-10-cm",
"version": "2025",
"code": "D61.810",
"display": "Antineoplastic chemotherapy induced pancytopenia"
},
{
"system": "http://hl7.org/fhir/sid/icd-10-cm",
"version": "2025",
"code": "D61.811",
"display": "Other drug-induced pancytopenia"
},
{
"system": "http://hl7.org/fhir/sid/icd-10-cm",
"version": "2025",
"code": "D61.818",
"display": "Other pancytopenia"
},
{
"system": "http://hl7.org/fhir/sid/icd-10-cm",
"version": "2025",
"code": "D61.82",
"display": "Myelophthisis"
},
{
"system": "http://hl7.org/fhir/sid/icd-10-cm",
"version": "2025",
"code": "D61.89",
"display": "Other specified aplastic anemias and other bone marrow failure syndromes"
},
{
"system": "http://hl7.org/fhir/sid/icd-10-cm",
"version": "2025",
"code": "D61.9",
"display": "Aplastic anemia, unspecified"
},
{
"system": "http://hl7.org/fhir/sid/icd-10-cm",
"version": "2025",
"code": "D63",
"display": "Anemia in chronic diseases classified elsewhere"
},
{
"system": "http://hl7.org/fhir/sid/icd-10-cm",
"version": "2025",
"code": "D63.0",
"display": "Anemia in neoplastic disease"
},
{
"system": "http://hl7.org/fhir/sid/icd-10-cm",
"version": "2025",
"code": "D63.1",
"display": "Anemia in chronic kidney disease"
},
{
"system": "http://hl7.org/fhir/sid/icd-10-cm",
"version": "2025",
"code": "D63.8",
"display": "Anemia in other chronic diseases classified elsewhere"
},
{
"system": "http://hl7.org/fhir/sid/icd-10-cm",
"version": "2025",
"code": "D64",
"display": "Other anemias"
},
{
"system": "http://hl7.org/fhir/sid/icd-10-cm",
"version": "2025",
"code": "D64.0",
"display": "Hereditary sideroblastic anemia"
},
{
"system": "http://hl7.org/fhir/sid/icd-10-cm",
"version": "2025",
"code": "D64.1",
"display": "Secondary sideroblastic anemia due to disease"
},
{
"system": "http://hl7.org/fhir/sid/icd-10-cm",
"version": "2025",
"code": "D64.2",
"display": "Secondary sideroblastic anemia due to drugs and toxins"
},
{
"system": "http://hl7.org/fhir/sid/icd-10-cm",
"version": "2025",
"code": "D64.3",
"display": "Other sideroblastic anemias"
},
{
"system": "http://hl7.org/fhir/sid/icd-10-cm",
"version": "2025",
"code": "D64.4",
"display": "Congenital dyserythropoietic anemia"
},
{
"system": "http://hl7.org/fhir/sid/icd-10-cm",
"version": "2025",
"code": "D64.8",
"display": "Other specified anemias"
},
{
"system": "http://hl7.org/fhir/sid/icd-10-cm",
"version": "2025",
"code": "D64.81",
"display": "Anemia due to antineoplastic chemotherapy"
},
{
"system": "http://hl7.org/fhir/sid/icd-10-cm",
"version": "2025",
"code": "D64.89",
"display": "Other specified anemias"
},
{
"system": "http://hl7.org/fhir/sid/icd-10-cm",
"version": "2025",
"code": "D64.9",
"display": "Anemia, unspecified"
}
]
}
}